Qure Ventures
Qure Ventures is a venture capital firm based in Herzliya, Israel, founded in 2012. It is notable for being Israel's first fund exclusively focused on digital health. The firm is led by experienced professionals from the digital health sector who have a track record of founding, growing, and exiting companies over the past two decades. Qure Ventures primarily invests in startups located in Israel, leveraging the country's prominent tech and digital health ecosystem. The firm has established strategic partnerships with key stakeholders across various domains, including consumers, providers, payers, and pharmaceuticals, which facilitates rapid access to market and clinical trial opportunities for its portfolio companies. Additionally, Qure Ventures benefits from the global network and medical expertise of its parent company, OurCrowd, enhancing its deal access and due diligence capabilities.
8 past transactions
CoreMap
Series B in 2022
CoreMap, Inc. is a medical technology company based in Winooski, Vermont, focused on developing advanced diagnostic solutions for electrophysiologists treating atrial fibrillation. Incorporated in 2016, the company offers a micro-electrode solution that allows for sequential mapping of tissue properties, addressing significant challenges in the treatment of atrial fibrillation, such as poor spatial resolution and inadequate sample density. Additionally, CoreMap's ultra-high resolution electrodes provide detailed insights into cardiac activation, even during episodes of fibrillation. By enhancing the diagnostic capabilities of electrophysiologists, CoreMap aims to improve patient outcomes in the management of this complex condition.
Sweetch
Series A in 2021
Sweetch is a behavioral science company that utilizes artificial intelligence and emotional intelligence to provide digital therapeutic solutions. The company has developed a hyper-personalized engagement platform designed to enhance clinical outcomes for individuals with chronic conditions. This platform offers tailored recommendations that consider the right timing, tone, and real-world context, guiding patients throughout their health journey. By catering to the specific needs of patients, Sweetch enables pharmaceutical companies, device manufacturers, payers, and healthcare providers to establish continuous relationships and effectively engage with each individual at scale.
Carevive Systems
Series C in 2021
Carevive Systems, Inc. is a healthcare technology company that specializes in enhancing cancer care delivery through its innovative platform. The company offers Carevive PROmpt, a comprehensive software solution designed for treatment planning, patient engagement, symptom management, and survivorship care. This platform includes features such as electronic patient-reported outcomes (ePRO), care coordination tools, and analytics that help oncology practices adapt to value-based care models. Carevive Systems also provides a Risk Stratification model to identify at-risk patients and develops symptom management plans based on clinical data and evidence-based guidelines. Founded in 2013 and based in North Miami, Florida, Carevive Systems aims to improve clinical outcomes and patient experiences by delivering personalized and continuously updated cancer care plans.
CoreMap
Series A in 2020
CoreMap, Inc. is a medical technology company based in Winooski, Vermont, focused on developing advanced diagnostic solutions for electrophysiologists treating atrial fibrillation. Incorporated in 2016, the company offers a micro-electrode solution that allows for sequential mapping of tissue properties, addressing significant challenges in the treatment of atrial fibrillation, such as poor spatial resolution and inadequate sample density. Additionally, CoreMap's ultra-high resolution electrodes provide detailed insights into cardiac activation, even during episodes of fibrillation. By enhancing the diagnostic capabilities of electrophysiologists, CoreMap aims to improve patient outcomes in the management of this complex condition.
CyberMDX
Series B in 2020
CyberMDX Technologies Inc., established in 2016 and headquartered in New York, specializes in medical cybersecurity. It offers a cloud-based solution, CyberMDX, which provides real-time visibility, protection, and operational insights for connected healthcare devices. The platform identifies and assesses vulnerabilities, detects and responds to threats, and ensures compliance, all while integrating seamlessly with existing environments. CyberMDX aims to safeguard patient safety and hospital operational continuity by preventing cyber incidents and mitigating risks associated with medical device security.
Sweetch
Convertible Note in 2020
Sweetch is a behavioral science company that utilizes artificial intelligence and emotional intelligence to provide digital therapeutic solutions. The company has developed a hyper-personalized engagement platform designed to enhance clinical outcomes for individuals with chronic conditions. This platform offers tailored recommendations that consider the right timing, tone, and real-world context, guiding patients throughout their health journey. By catering to the specific needs of patients, Sweetch enables pharmaceutical companies, device manufacturers, payers, and healthcare providers to establish continuous relationships and effectively engage with each individual at scale.
CyberMDX
Series A in 2018
CyberMDX Technologies Inc., established in 2016 and headquartered in New York, specializes in medical cybersecurity. It offers a cloud-based solution, CyberMDX, which provides real-time visibility, protection, and operational insights for connected healthcare devices. The platform identifies and assesses vulnerabilities, detects and responds to threats, and ensures compliance, all while integrating seamlessly with existing environments. CyberMDX aims to safeguard patient safety and hospital operational continuity by preventing cyber incidents and mitigating risks associated with medical device security.
BrainQ
Venture Round in 2018
BrainQ is a company that specializes in developing precision neurology therapies aimed at treating impaired brain functions. Founded in 2016 and headquartered in Jerusalem, Israel, BrainQ utilizes a brain-computer interface (BCI)-based approach to target damaged neuronal networks and promote neuro recovery. By integrating machine learning algorithms with neuroscience, the company extracts biological insights that inform the creation of tailored therapies. This innovative approach aims to empower individuals with neurological disorders, helping them achieve greater independence and improved quality of life.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.